Form 4 holding
Director, Chairman of the Board
ARCA biopharma, Inc.
- Security class
- Common Stock
- Shares / value
- 50,000
- Estimated value
- $125,000
- Report date
- 30 Jan 2024
- Price
- $2.50
- Ownership
- Direct
Robert E. Conway - Director, Chairman of the Board at Oruka Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director, Chairman of the Board
- Issuer ticker
- ORKA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Robert E. Conway since 13 Sep 2025
Reported holdings for Robert E. Conway in Oruka Therapeutics, Inc.
Form 4 holding
Director, Chairman of the Board
ARCA biopharma, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 6,000
- Estimated value
- Report date
- 30 Jan 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Robert E. Conway in Oruka Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.